Download PDF
Dtsch Med Wochenschr 2020; 145(01): 29-34
DOI: 10.1055/a-0793-4544
Dossier
© Georg Thieme Verlag KG Stuttgart · New York

Lyme-Borreliose: Serologische und mikrobiologische Diagnostik und Differenzialdiagnostik

Lyme Borreliosis: Serological and Microbiological Diagnostics and Differential Diagnosis
Volker Fingerle
,
Andreas Sing
Further Information

Publication History

Publication Date:
08 January 2020 (online)

Also available at
    Permissions and Reprints

Abstract

Lyme borreliosis caused by at least six Borrelia burgdorferi species, is the most important tick-borne disease in the northern hemisphere. With a wide spectrum of possible symptoms, the microbiological diagnosis of this disease is associated with a wide variety of ideas, divergent approaches and much uncertainty. The aim of the article is to introduce the treating physicians to a meaningful microbiological diagnostic procedure. Most important messages include that (I) the suspected diagnosis of Lyme borreliosis is first based on anamnestic data and clinical symptoms (compare “case definitions”) which is substantiated by microbiological examinations; (II) microbiological diagnostics – primarily antibody detection, downstream PCR and culture – are only indicated if there are indicative symptoms, with typical erythema migrans not requiring microbiological diagnostics; (III) keep in mind: The more unspecific the symptoms are the lower the positive and the higher the negative predictive value of microbiological testing; (IV) serological diagnosis should follow a two-step procedure: a sensitive ELISA as first step, if reactive followed by immunoblot (IgM and IgG). Detection rates are ca. 50 % in localized, 70– > 90 % in disseminated early and nearly 100 % (only IgG relevant) in late disease; (V) in the immunoblot early forms of disease show a narrow band spectrum, late forms show a broad spectrum; (VI) methods that are not recommended for diagnostic purposes include lymphocyte activation or transformation tests (LTT, MELISA, ELISPOT), PCR or antigen detection from urine or blood, lymphocyte subpopulations, or direct detection of borreliae from patient material using dark field- or focus floating microscopy.

Die durch Borrelia burgdorferi verursachte Lyme-Borreliose ist die häufigste durch Zecken übertragene Erkrankung in der nördlichen Hemisphäre. Bei schon breitem Spektrum möglicher Symptome ist auch die mikrobiologische Diagnostik mit unterschiedlichsten Vorstellungen, divergierenden Vorgehensweisen und viel Unsicherheit assoziiert. Dieser Beitrag stellt dem Behandler ein sinnvolles mikrobiologisch-diagnostisches Vorgehen vor.

Schlüsselwörter

Borrelia burgdorferi - Lyme-Borreliose - Diagnostik

Key words

Borrelia burgdorferi - Lyme borreliosis - diagnostic
 

  • Literatur

  • 1 Fingerle V, Eiffert H, Gessner A. et al. MiQ12 Lyme-Borreliose. In: Podbielski A, Herrmann M, Kniehl E. Hrsg. MiQ: Qualitätsstandards in der mikrobiologisch-infektiologischen Diagnostik. München, Jena: Urban & Fischer; 2017: 1-68
    Google Scholar
  • 2 Rauer S, Kastenbauer S, Hofmann H. et al. Neuroborreliose, S3-Leitlinie 2018. In: Deutsche Gesellschaft für Neurologie, Hrsg. Leitlinien für Diagnostik und Therapie in der Neurologie. Im Internet: www.dgnorg/leitlinien2018 ; Stand: 15.11.2019
    PubMedGoogle Scholar
  • 3 Hofmann H, Rauer S. Leitlinienkoordination. Kutane Borreliose. AWMF Leitlinie, Deutsche Dermatologische Gesellschaft. 2016: 1-65 ; Im Internet: www.awmf.org/leitlinien/detail/ll/013-044.html ; Stand: 15.11.2019
    PubMedGoogle Scholar
  • 4 Lohr B, Fingerle V, Norris DE. et al. Laboratory diagnosis of Lyme borreliosis: Current state of the art and future perspectives. Crit Rev Clin Lab Sci 2018; 55: 219-245
    CrossrefPubMedGoogle Scholar
  • 5 Stanek G, Fingerle V, Hunfeld KP. et al. Lyme borreliosis: clinical case definitions for diagnosis and management in Europe. Clin Microbiol Infect 2011; 17: 69-79
    CrossrefPubMedGoogle Scholar
  • 6 Dessau RB, van Dam AP, Fingerle V. et al. To test or not to test? Laboratory support for the diagnosis of Lyme borreliosis: a position paper of ESGBOR, the ESCMID study group for Lyme borreliosis. Clin Microbiol Infect 2018; 24: 118-124
    CrossrefPubMedGoogle Scholar
  • 7 Wilking H, Fingerle V, Klier C. et al. Antibodies against Borrelia burgdorferi sensu lato among Adults, Germany, 2008–2011. Emerg Infect Dis 2015; 21: 107-110
    CrossrefPubMedGoogle Scholar
  • 8 Leeflang MM, Ang CW, Berkhout J. et al. The diagnostic accuracy of serological tests for Lyme borreliosis in Europe: a systematic review and meta-analysis. BMC Infect Dis 2016; 16: 140
    CrossrefPubMedGoogle Scholar
  • 9 Koedel U, Fingerle V, Pfister HW. Lyme neuroborreliosis-epidemiology, diagnosis and management. Nat Rev Neurol 2015; 11: 446-456
    PubMedGoogle Scholar
  • 10 Rupprecht TA, Manz KM, Fingerle V. et al. Diagnostic value of cerebrospinal fluid CXCL13 for acute Lyme neuroborreliosis. A systematic review and meta-analysis. Clin Microbiol Infect 2018; 24: 1234-1240
    CrossrefPubMedGoogle Scholar
  • 11 Krause A, Fingerle V. Wenn Zecken Borrelien bescheren…. CME 2009; 6: 46-55
    CrossrefPubMedGoogle Scholar